Buradasınız

Anasayfa » Content

Sağlık Hizmetleri Piyasasında Asimetrik Bilgiye Bağlı Problemler ve Çözüm Önerileri

Problems Based on Asymmetric Information i n Healthcare Market and Resolutıons

Journal Name:

  • Hacettepe Sağlık İdaresi Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
According to the theoretical and empirical studies in health care markets in the last years, health expenditures have been rising relatively. The basic reasons of increased health expenditures are an average increase in life time, development of health acknowledgement among people, use of advanced technology and especially the problems due to asymmetric information. The problems related to asymmetric information are adverse selection, moral hazard and induced supplier demand. Health economists and healthcare policymakers propose the supply side cost sharing, demand side cost sharing and mixed payment system for the problems dealt with asymmetric information. Some researchers suggest that health expenditures would decrease if the patients met their healthcare expenditure by themselves. On the other hand, some other researcher’s claim that the above suggestion wouldn’t be reasonable since healthcare market has some special rules and different market structure from other markets. Health services are over consumed and hence costs tend to increase when uncertainty, asymmetric information and health insurance of health service market are given in health care market. The success of cost sharing approach depends on standardization of the possibility of health care services measured and assessed.
Bookmark/Search this post with
Abstract (Original Language): 
Son yıllarda sağlık hizmetleri piyasası alanında yapılan teorik ve ampirik çalışmalara göre, sağlık harcamaları nispeten hızlı artış göstermektedir. Sağlık harcamalarındaki artışın temel nedenleri olarak; nüfusun yaşlanması, sağlık bilincinin artması, ileri teknoloji kullanımının yaygınlaşması gibi faktörler yanında özellikle asimetrik bilgiye bağlı problemlere dikkat çekilmektedir. Asimetrik bilgiye bağlı problemler; ters seçim, ahlaki tehlike ve arzın talep yaratmasıdır. Sağlık iktisatçıları ve politika yapıcılar asimetrik bilginin neden olduğu problemlere çözüm olarak; arz yanlı maliyet paylaşımı, talep yanlı maliyet paylaşımı ve karma ödeme sistemini önermektedirler. Araştırmacıların bir kısmı, sağlık piyasasındaki aktörlerin maliyete katlanmaları durumunda sağlık harcamalarında düşüş olacağını savunmaktadır. Diğer bir kısmı ise sağlık hizmetleri piyasasının kendine özgü kuralları ve piyasa yapısı nedeniyle uygulamanın başarılı olamayacağını ifade etmektedir. Sağlık hizmetleri piyasasında belirsizlik, asimetrik bilgi ve sağlık sigortası veri iken sağlık hizmetleri aşırı tüketilmekte ve maliyetler artmaktadır. Maliyet paylaşımı yaklaşımının başarılı olabilmesi, sağlık hizmetlerinin ölçülebilir ve değerlendirilebilir standart bir yapıya kavuşturulmasına bağlıdır.
FULL TEXT (PDF): 
PDF icon arastirmax-saglik-hizmetleri-piyasasinda-asimetrik-bilgiye-bagli-problemler-cozum-onerileri.pdf
  • 2
201-228
  • Turkish

REFERENCES

References: 

1. Abbring J. H.; Chiappori P. A.; Heckman J. J. and Pinquet J. (2003)
“Adverse Selection and Moral Hazard in Insurance: Can Dynamic Data
Help to Distinguish?”, European Economic Association, 1(3): 1-12.
2. Akerlof G. (1970) “The Market for Lemons: Qualitative Uncertainty and
the Market Mechanism”, Quarterly Journal of Economy, 84: 488-500.
3. Arrow K. J. (1963) “Uncertainty and the Welfare Economics of Medical
Care”, American Economic Review, 53: 941-973.
4. Blomqvist A. and Leger P. T. (2003), “Information Asymmetry, Insurance
and the Decision to Hospitalize”, www.ntz.fas nus.edu.Org /ecs/pub /wp
0305pdf, [04.05.2007].
5. Cheng S. and Chiang T. (1997) “The Effect of Universal Health Insurance
on Health care Utilization in Taiwan”, Journal of American Association,
278: 89-93.
6. Culyer A. J. (1983) The Political Economy of Social Policy, Oxford
University Press, Oxford.
7. Eggleston K. and Hsieh C. R. (2004), “Health Care Payment Incentives: A
Comparative Analysis of Reforms in Taiwan, Korea and China”,
Department of Economics Tufts University, Medford,
www.ase.tufts.edu/econ [05.08.2006].
8. Eggleston K. (2004) “Competition, Altruism and Provider Payment”,
Department of Economics Tufts University, Medford,
www.asetufts.edu/econ. [02.07.2005].
Sağlık Hizmetleri Piyasasında Asimetrik Bilgi 225
9. Erdem R. ve Yıldırım H. H. (2003) “Sağlık Hizmetlerinde Vekalet İlişkisi
ve Arzın Talep Yaratması Problemi”, Hacettepe Sağlık İdaresi Dergisi,
6(2): 1-22.
10. European Competitiveness Report (2007), www.ec.europa.eu/
enterprise/ict/index, [10.03.2007].
11. Farley D. E. (1985) “Competition Among Hospitals: Market Structure and
its Relation to Utilization, Costs and Financial Position”, National Center
for Health Services Research and Health Care Technology Assessment.
12. Feldstein M. S. (1973) “The Welfare Loss of Excess Health Insurance”,
Journal of Political Economy, 81: 251-80.
13. Flood C. (2001) “International Experience With Managed Care, Managed
Competition and Internal Markets: Lessons From Canada”,
www.parl.gc.ca/37/1/parlbus/commbus/senate/com-E/SOCI-E/rep-e/volume3ver..., [01.06.2007].
14. Frank R. G.; Glazer J. and McGuire T. (1997) “Measuring Adverse
Selection in Managed Health Care”, Journal of Health Economics, 19:
829-854.
15. Fuchs V. R. and Zeckhauser R. (1987) “Valuing Health A Priceless
Commodity”, American Economic Review, 77(2): 5-27.
16. Fuchs V. R. (1978) “The Economics of Physician and Patient Behavior”.
The Journal of Human Resources, XIII. In Joseph N. (ed.) University of
Wisconsin Press, Madison.
17. Gaynor M. (1994) “Issues in the Industrial Organization of the Market for
Physician Services”, Journal of Economics and Management Strategy,
(3): 211-255.
18. Gaynor M. (2006) “What Do We Know About Competition and Quality in
Healthcare Markets?”, Carnegie Mellon University: 1-40.
226 Hacettepe Sağlık İdaresi Dergisi, Cilt:11, Sayı:2 (2008)
19. Gaynor M. and Haas-Wilson D. (1998) “The Blessing and the Curse of
Managed Care: Vertical Relations in Health Care Markets”, American
Enterprise Institute Press.
20. Gaynor M. and Vogt W. B. (1999) “Antitrust and Competition in Health
Care Markets”, Rand Journal of Economics: 1-42.
21. Gerdtham U. G. and Jonsson B. (2000) “International Comparisons of
Health Expenditure”, Handbook of Health Economics, 1: 11-53.
22. Hemenway D. and Fallon D. (1985) “Testing for Physician-Induced
Demand with Hypothetical Cases”, Medical Care, 23(4): 344-349.
23. Hickson G. B.; Altemeier W. A. and Perrin J. M. (1987) “Physician
Reimbursement by Salary or Fee-For-Service: Effect on Physician’s
Practice Behaviour in a Randomized Prospective Study”, Pediatrics, 80:
744-750.
24. Kornai J. and Eggleston K. (2001) “Choice and Solidarity: the Health
Sector in Eastern Europe and Proposal for Reform”, International
Journal of Health care Finance and Economics, 1: 59-84.
25. Krasnick A., Groenewegen P. and Pedersen P. (1990) “Changing
Reimbursement System: Effect on Activity in General Practice”, British
Medical Journal, 360: 1698-1701.
26. Kurtulmuş S. (1998) Sağlık Ekonomisi ve Hastane Yönetimi. Değişim
Dinamikleri Yayınları, İstanbul.
27. Miyazaki H. (1977) “The Rat Race and Internal Labor Markets”, Bell
Journal of Economics, 8: 394-418.
28. Montefiori M. (2004) “Patient Behavior in the Market for Hospital
Services”, www.disefin.unige.it/finanza/WP%5Cn42003.pdf [12.08.2006].
29. Mukamel B. D.; Zwanziger J. and Bamezai A. (2002) “Hospital
Competition, Resource Allocation and Quality of Care”, BMC Health
Services Research, 2(10): 1-9.
Sağlık Hizmetleri Piyasasında Asimetrik Bilgi 227
30. Newhouse J. P. (2002) Pricing the Priceless: A Health Care
Conundrum, MIT Press, Cambridge.
31. Noguchi H. and Shimizutani S. (2005) “Supplier Induced Demand in
Japan’s At-home Care Industry: Evidence From Micro-Level survey on
Care Receivers”. www.esri.go.jp/jp/archive/e_dis/e_dis150/e_dis148a.pdf
[15.06. 2007].
32. Normand C. (1991) “Economics, Health, and Economics of Health”, BMJ,
303: 21-28.
33. Pauly M. V. (1968) “The Economics of Moral Hazard: Comment”,
American Economic Review, (58): 531–537.
34. Rothschild M. and Stiglitz J. (1976) “Equilibrium in Competitive Insurance
Markets: An Essay on the Economics of Imperfect Information”,
Quarterly Journal of Economics, 90(4): 629-649.
35. Saatçi M. ve Ecevit E. (2007) “Tüberküloz Hastalığının Ekonomik Yükü:
Nuh Naci Yazgan Göğüs Hastalıkları Hastanesi’nde Bir Uygulama”,
Erciyes Üniversitesi Sosyal Bilimler Enstitüsü Dergisi, 22: 217-229.
36. Schneider U. (2004) “Asymmetric Information and the Demand for Health
Care - the Case of Double Moral Hazard”, www.129.3.20.41/
eps/hew/papers/0409 [21.03. 2006].
37. Schneider U. and Ulrich V. (2002) “Asymmetric Information and
Outcome-Based Compensation in Health Care - Theoretical Implications”,
www.papers.ssrn.com/sol3/papers.cfm [12.04. 2006].
38. Schneider U. and Ulrich V. (2005) “The Physician-Patient Relationship
Revisited: the Patient’s View”, www.129.3.20.41/eps/hew/papers/
0505/0505001.pdf [07.01. 2007].
39. Shmanske S. (1996) “Information Asymmetries in Health Services: The
Market Can Cope”, The Independent Review, 1(2): 191-200.
228 Hacettepe Sağlık İdaresi Dergisi, Cilt:11, Sayı:2 (2008)
40. Spence M. (1978) “Product Differentiation and Performance in Insurance
Markets”, Journal of Public Economics, 10: 427-447.
41. Weisbrod B. A. (1991) “Competition in Health Care: A Cautionary View”,
Institute For Research on Poverty Discussion Paper, University of
Wisconsin: 678-81.
42. WHO (2007), http/www.who.int/nha/Pie-2007-Large.pdf [11.10.2007].
43. Wilensky G. R. and Rossiter L. F. (1983) “The Relative Importance of
Physician-Induced Demand in the Demand for Medical Care”, Health and
Society, 61(2): 252-277.

Thank you for copying data from http://www.arastirmax.com